Skip to main content
SpringerLink
Log in

Changes of QTc interval after opioid switching to oral methadone

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

A consecutive sample of patients who were switched from strong opioids to methadone in a period of 1 year was surveyed. QTc was assessed before switching (T0) and after achieving adequate analgesia and an acceptable level of adverse effects (Ts). Twenty-eight of 33 patients were switched to methadone successfully. The mean initial methadone doses at T0 were 67.1 mg/day (SD ±80.2, range 12–390). The mean QTc interval at T0 was 400 ms (SD ±30, range 330–450). The mean QTc interval at Ts (median 5 days) was 430 ms (SD ±26, range 390–500). The difference (7.7 %) was significant (p < 0.0005). Only two patients had a QTc of 500 ms. No serious arrhythmia was observed. At the linear regression analysis, there was no significant association between mean opioid doses expressed as oral morphine equivalents and QTc at T0 (p = 0.428), nor between mean methadone doses and QTc at Ts (p = 0.315). No age differences were found with previous opioid doses (p = 0.917), methadone doses (p = 0.613), QTc at T0 (p = 0.173), QTc at Ts (p = 0.297), and final opioid–methadone conversion ratio (p = 0.064). While methadone used for opioids switching seems to be an optimal choice to improve the opioid response in patients poorly responsive to the previous opioid, the possible QTc prolongation should be of concern despite not producing clinical consequences in this group of patients. A larger number of patients should be assessed to quantify the risk of serious arrhythmia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Caraceni A, Hanks G, Kaasa S (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58–e68

    Article  PubMed  CAS  Google Scholar 

  2. Cruciani R, Sekine R, Homel P (2005) Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 29:385–391

    Article  PubMed  CAS  Google Scholar 

  3. Cruciani R (2008) Methadone: to ECG or not ECG… That is still the question. J Pain Symptom Manage 36:545–552

    Article  PubMed  CAS  Google Scholar 

  4. Florian J, Garnett CE, Nallani SC, Rappaport BA, Throckmorton DC (2012) A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials. Clin Pharmacol Ther 91:666–672

    Article  PubMed  CAS  Google Scholar 

  5. Fredheim OM, Borchgrevink PC, Hrgrenaes L, Kaasa S, Dale O, Klepstad P (2006) Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: a prospective 9-month follow-up study. J Pain Symptom Manage 32:180–185

    Article  PubMed  CAS  Google Scholar 

  6. Gourevitch M (2009) First do not harm…. reduction? Ann Intern Med 150:417–418

    Article  PubMed  Google Scholar 

  7. Kornick CA, Kilborn MJ, Santiago-Palma J et al (2003) QTc interval prolongation associated with intravenous methadone. Pain 105:499–506

    Article  PubMed  CAS  Google Scholar 

  8. Krantz MJ, Lewkowlez L, Hays H, Woodroffe M, Robertson A (2002) Torsades de points associated with very-high dose methadone. Ann Intern Med 137:501–504

    Article  PubMed  CAS  Google Scholar 

  9. Krantz MJ, Lowery C, Martell B, Gourevitch M, Arnsten J (2005) Effects of methadone on QT-interval dispersion. Pharmacotherapy 25:1523–1529

    Article  PubMed  CAS  Google Scholar 

  10. Krantz MJ (2008) Heterogeneous impact of methadone on the QTc interval: what are the practical implications? J Addict Dis 27:5–9

    Article  PubMed  Google Scholar 

  11. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC (2009) QTc interval screening in methadone treatment. Ann Intern Med 150:387–395

    Article  PubMed  Google Scholar 

  12. Maremmani I, Pacini M, Cesaroni C et al (2005) QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 11:44–49

    Article  PubMed  Google Scholar 

  13. Martell B, Arnsten J, Ray B, Gourevitch M (2003) The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med 139:154–155

    Article  PubMed  Google Scholar 

  14. Martell B, Arnsten J, Ray B, Krantz M, Gourevitch M (2005) Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 95:915–918

    Article  PubMed  CAS  Google Scholar 

  15. Mayet S, Gossop M, Lintzeris N, Markides V, Strang J (2011) Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev 30:388–396

    Article  PubMed  Google Scholar 

  16. Mercadante S (2012) Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med 13:399–404

    Article  PubMed  Google Scholar 

  17. Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S (2009) Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 37:632–641

    Article  PubMed  Google Scholar 

  18. Mercadante S, Bruera E (2006) Opioid switching: a systematic and critical review. Cancer Treat Rev 32:304–315

    Article  PubMed  CAS  Google Scholar 

  19. Mercadante S, Caraceni A (2011) Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 25:504–515

    Article  PubMed  Google Scholar 

  20. Ministero della salute. (2003) Bollettino di informazione sui farmaci, anno X, n-5.6.

  21. Ower K, Morley-Forster P, Moulin D (2005) Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain. J Opioid Manage 1:73–76

    Google Scholar 

  22. Pearson EC, Woosly R (2005) QT prolongation and torsades de pointes among methadone users; report to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 14:747–753

    Article  PubMed  CAS  Google Scholar 

  23. Peles E, Bodner G, Kreek M, Rados V, Adelson M (2006) Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients—a cross-sectional study. Addiction 102:289–300

    Article  Google Scholar 

  24. Reddy S, Fisch M, Bruera E (2004) Oral methadone for cancer pain: no indication of QT interval prolongation or torsade de pointes. J Pain Symptom Manage 28:301–303

    Article  PubMed  Google Scholar 

  25. Reddy S, Hui D, El Osta B et al (2010) The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med 13:33–38

    Article  PubMed  Google Scholar 

  26. Roy AK, McCarthy C, Kiernan G et al (2010) Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Addiction 107:1132–1139

    Article  Google Scholar 

  27. Shah RR (2013) Drug-induced QT interval prolongation: does ethnicity of the through QT study population matter? Br J Clin Pharmacol 75:347–358

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Cancer Pain and Palliative Care Unit, La Maddalena Cancer Center, Via San Lorenzo 312, 90146, Palermo, Italy

    Sebastiano Mercadante, Giovanna Prestia & Claudio Adile

  2. Clinical Neuroscience, University of Palermo, Palermo, Italy

    Alessandra Casuccio

Authors
  1. Sebastiano Mercadante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanna Prestia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudio Adile
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandra Casuccio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastiano Mercadante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercadante, S., Prestia, G., Adile, C. et al. Changes of QTc interval after opioid switching to oral methadone. Support Care Cancer 21, 3421–3424 (2013). https://doi.org/10.1007/s00520-013-1928-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-1928-y

Keywords

Search

Navigation